Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

• Type of Material: Article
• Authors: Mariah M Johnson, Oregon Health & Science University; Sancy A Leachman, Oregon Health & Science University; Lisa G Aspinwall, University of Utah; Lee D Cranmer, University of Washington; Clara Curiel-Lewandrowski, University of Arizona; Vernon K Sondak, Moffitt Cancer Center; Clara E Stemwedel, Oregon Health & Science University; Susan M Swetter, Stanford University; John Vetto, Oregon Health & Science University; Tawnya Bowles, University of Utah; Robert P Dellavalle, University of Colorado; Larisa J Geskin, Columbia University; Douglas Grossman, University of Utah; Kenneth F Grossmann, University of Utah; Jason E Hawkes, University of Utah; Joanne M Jeter, The Ohio State University; Caroline C Kim, Harvard Medical School; John M Kirkwood, University of Pittsburgh; Aaron R Mangold, Mayo Clinic Arizona; Frank Meyskens, University of California; Michael E Ming, University of Pennsylvania; Brian Pollack, Emory University; Suephy Chen, Emory University; David Lawson, Emory University; Oliver Wisco, Emory University
• Language: English
• Date: 2017-03
• Publisher: Future Medicine
• Publication Version: Final Published Version
• Copyright Statement: © 2016 Sancy Leachman
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.2217/mmt-2016-0022
• Title of Journal or Parent Work: Melanoma Management
• ISSN: 2045-0885
• Volume: 4
• Issue: 1
• Start Page: 13
• End Page: 37
• Keywords: skin cancer; melanoma odds ratio; melanoma; screening; USPSTF; keratinocyte carcinoma; guidelines; early detection; melanoma relative risk; melanoma risk factors
• Research Categories: Health Sciences, Oncology; Health Sciences, Health Care Management

Abstract

Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is responsible for the majority of skin cancer-related deaths. Currently, there is no national consensus on skin cancer screening in the USA, but dermatologists and primary care providers are routinely confronted with making the decision about when to recommend total body skin examinations and at what interval. The objectives of this paper are: to propose rational, risk-based, data-driven guidelines commensurate with the US Preventive Services Task Force screening guidelines for other disorders; to compare our proposed guidelines to recommendations made by other national and international organizations; and to review the US Preventive Services Task Force's 2016 Draft Recommendation Statement on skin cancer screening.